الشارقة 24
الشارقة 24
Ready to play
Ready to play
A study at the University of Cambridge revealed that a vaccine, fully developed using artificial intelligence and tested on humans, achieved limited results in boosting immunity. It failed to significantly increase antibody responses in about thirty individuals who received it. Despite the disappointing vaccine outcomes, researchers considered it a significant methodological advancement, as it is the first vaccine entirely designed through algorithms that rely on genetic data from coronavirus variants, aiming to predict the future evolution of adaptable viruses. The study also showed that the vaccine did not cause serious side effects, paving the way for further trials.
Notice: This Is an AI-Generated Summary
Comments (0)